API australian pharmaceutical industries limited
Add to My Watchlist 0.00% ! $1.53

News: API Australian Pharmaceutical Industries gets sweetened $560 mln buyout bid from Wesfarmers

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    16/09/21
    10:00
    Post #: 56106797

    Sept 16 (Reuters) - Australian Pharmaceutical Industries (API) (API) said on Thursday it received a sweetened indicative bid from retail conglomerate Wesfarmers (WES) , valuing the pharmaceutical company at A$763.6 million ($560.25 million).

    As per the new bid, API shareholders would now receive A$1.55 per share, up from the previous offer of A$1.38 apiece that was rejected in July.

    ($1 = 1.3630 Australian dollars)

    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
NEWS Harness the power of Australia’s leading investor community
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.